Daniel P Lemanu1, Primal P Singh2, Habib Rahman3, Andrew G Hill2, Richard Babor3, Andrew D MacCormick2. 1. Department of Surgery, South Auckland Clinical School, University of Auckland, Auckland, New Zealand; Department of Surgery, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand. Electronic address: daniel_lemanu@hotmail.com. 2. Department of Surgery, South Auckland Clinical School, University of Auckland, Auckland, New Zealand; Department of Surgery, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand. 3. Department of Surgery, Middlemore Hospital, Counties Manukau District Health Board, Auckland, New Zealand.
Abstract
BACKGROUND: Whilst the early to mid-term efficacy of laparoscopic sleeve gastrectomy (SG) is well established, there is comparatively less detailing of long-term efficacy. The objectives of this study were to evaluate the long-term outcomes of patients undergoing SG at the authors' institution. METHODS: All patients undergoing SG during the past 5 or more years were eligible. Outcomes included baseline demographic data, preoperative characteristics, percentage excess weight loss (%EWL), co-morbidity improvement and resolution, serum hemoglobin A(1c) (HbA(1c)), serum lipid profile, and the Bariatric Analysis Reporting Outcome System (BAROS) questionnaire. A subset analysis was also performed with patients stratified in to super obese (body mass index ≥ 50 kg/m(2)). RESULTS: There were 96 patients who underwent surgery between March 2007 and July 2008. Of these, 10 declined to participate, 28 were unable to be contacted, and 3 were deceased; therefore, 55 patients were included in the analysis. The mean yearly %EWL to postoperative year 5 was 56% (year 1), 55% (year 2), 46% (year 3), 43% (year 4), and 40% (year 5). Combined improvement and resolution rates at 5 years were 79%, 61%, and 73% for type 2 diabetes, hypertension, and obstructive sleep apnea, respectively. The HbA(1c) was significantly reduced at long-term follow-up. The mean BAROS score was 3.13 (95% CI: 2.4, 3.9). Weight loss outcomes were less favorable in super obese patients. CONCLUSION: Weight loss outcomes at 5 year follow-up were modest after SG though improvement in co-morbidity status was maintained.
BACKGROUND: Whilst the early to mid-term efficacy of laparoscopic sleeve gastrectomy (SG) is well established, there is comparatively less detailing of long-term efficacy. The objectives of this study were to evaluate the long-term outcomes of patients undergoing SG at the authors' institution. METHODS: All patients undergoing SG during the past 5 or more years were eligible. Outcomes included baseline demographic data, preoperative characteristics, percentage excess weight loss (%EWL), co-morbidity improvement and resolution, serum hemoglobin A(1c) (HbA(1c)), serum lipid profile, and the Bariatric Analysis Reporting Outcome System (BAROS) questionnaire. A subset analysis was also performed with patients stratified in to super obese (body mass index ≥ 50 kg/m(2)). RESULTS: There were 96 patients who underwent surgery between March 2007 and July 2008. Of these, 10 declined to participate, 28 were unable to be contacted, and 3 were deceased; therefore, 55 patients were included in the analysis. The mean yearly %EWL to postoperative year 5 was 56% (year 1), 55% (year 2), 46% (year 3), 43% (year 4), and 40% (year 5). Combined improvement and resolution rates at 5 years were 79%, 61%, and 73% for type 2 diabetes, hypertension, and obstructive sleep apnea, respectively. The HbA(1c) was significantly reduced at long-term follow-up. The mean BAROS score was 3.13 (95% CI: 2.4, 3.9). Weight loss outcomes were less favorable in super obesepatients. CONCLUSION:Weight loss outcomes at 5 year follow-up were modest after SG though improvement in co-morbidity status was maintained.
Authors: Attila Csendes; Ana María Burgos; Gustavo Martinez; Manuel Figueroa; Jaime Castillo; Juan Carlos Díaz Journal: Obes Surg Date: 2018-11 Impact factor: 4.129
Authors: Daniel M Felsenreich; Felix B Langer; Christoph Bichler; Magdalena Eilenberg; Julia Jedamzik; Ivan Kristo; Natalie Vock; Lisa Gensthaler; Charlotte Rabl; Alexander Todoroff; Gerhard Prager Journal: Obes Surg Date: 2020-04 Impact factor: 4.129